VSIG4 and metabolic dysfunction-associated steatohepatitis: Although Vsig4 also is not an entirely KC-specific biomarker, the results of this study demonstrated that its effectiveness in imaging NASH and autoimmune hepatitis was not significantly reduced by this lack of specific expression [151,154].